Is ALGBE.PA stock a buy after the drop?

ALGBE.PA stock looks like an oversold trading candidate, not a clear buy for long-term investors. Fundamentals show EPS **-0.32** and negative cash flow. If you trade a bounce, use tight stops, small size, and wait for volume above **80,000** for confirmation.

What short-term price target should traders use for ALGBE.PA?

We recommend an initial short-term target of **€0.03** and a secondary target of **€0.06** if volume and news confirm a reversal. Targets reflect technical resistance and the stock's low base, not guaranteed returns.

How does Meyka AI rate ALGBE.PA and what does it mean?

Meyka AI rates ALGBE.PA with a score of **68.40** out of 100 (Grade B, Suggestion: HOLD). The grade blends benchmarks, sector, growth and key metrics. It is informational and not investment advice.

What are the main risks for an oversold bounce trade in ALGBE.PA?

Main risks include further dilution, execution delays, low liquidity and a debt-to-equity ratio of **3.34**. Stops near **€0.0150** and strict position sizing are essential to manage downside risk on EURONEXT.

EU Stocks

ALGBE.PA Global Bioenergies (EURONEXT) €0.02: oversold bounce, eye €0.03 target

ByDanny Kontos March 13, 2026

ALGBE.PA stock trades at €0.0185 intraday on EURONEXT on 13 Mar 2026, marking a deeply oversold level after multi-period declines. The current price sits near the 52-week low of €0.0173 with a 50-day average of €0.01982, creating a short-term mean-reversion opportunity for active traders. Volume today is 32,615 shares versus an average of 81,160, and recent fundamentals show EPS -0.32, underlining high operational risk. We assess a measured oversold bounce trade with clear entry, stop and a short-term price target of €0.03